These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Fate of recurrent acute interstitial cellular rejection in an HLA identical kidney transplant recipient: impact of donor microchimerism. Chen Y; Baltzan M; George D; Bohm C; Okasha K; Shoker A Clin Nephrol; 1997 Nov; 48(5):300-6. PubMed ID: 9403214 [TBL] [Abstract][Full Text] [Related]
46. Characterization of rejection episodes in patients following positive crossmatch and ABO-incompatible live donor renal transplantation. Kayler LK; Farber JL; Colombe B; LaCava D; Friedewald JJ; Ratner LE Transpl Int; 2006 Feb; 19(2):128-39. PubMed ID: 16441362 [TBL] [Abstract][Full Text] [Related]
47. Antibody-mediated rejection in ABO compatible husband to wife living donor liver transplant and review of the literature. Kheradmand T; Anthony TL; Harland RC; Testa G; Hart J; Renz J; Te HS; Marino SR Hum Immunol; 2014 Jun; 75(6):578-83. PubMed ID: 24530823 [TBL] [Abstract][Full Text] [Related]
48. Hyperacute renal allograft rejection in the primate. Intrarenal effects of heparin and associated net release of factor VIII activity and kallikrein activation. Busch GJ; Kobayashi K; Hollenberg NK; Birtch AG; Colman RW Am J Pathol; 1975 Jul; 80(1):1-20. PubMed ID: 1098475 [TBL] [Abstract][Full Text] [Related]
49. Hyperacute allograft rejection mediated by IgM antibodies and a negative lymphocyte crossmatch: report of two cases. Demirhan B; Karakayali H; Turan M; Güngen Y; Bilgin N Transplant Proc; 1998 May; 30(3):732-3. PubMed ID: 9595077 [No Abstract] [Full Text] [Related]
50. IgG donor-specific crossmatches are not associated with graft rejection or poor graft survival after liver transplantation. An assessment by cytotoxicity and flow cytometry. Donaldson PT; Thomson LJ; Heads A; Underhill JA; Vaughan RW; Rolando N; Williams R Transplantation; 1995 Nov; 60(9):1016-23. PubMed ID: 7491675 [TBL] [Abstract][Full Text] [Related]
51. Evidence for cellular immune mechanisms in hyperacute rejection of renal allografts in miniature swine. Kirkman RL; Flye MW; Williams GM; Colvin RB; Sachs DH Transplant Proc; 1979 Mar; 11(1):790-2. PubMed ID: 377713 [No Abstract] [Full Text] [Related]
52. A Model of Acute Antibody-Mediated Renal Allograft Rejection in the Sensitized Rata. Chandran SR; Mulley WR; Kanellis J; Nikolic-Paterson DJ; Ma FY Exp Clin Transplant; 2018 Jun; 16(3):294-300. PubMed ID: 28760115 [TBL] [Abstract][Full Text] [Related]
53. [Xenotransplantation: physiopathology of hyperacute and differentiated rejection, and therapeutic perspectives]. Malassagne B; Calmus Y; Houssin D; Weill B Pathol Biol (Paris); 2000 May; 48(4):377-82. PubMed ID: 10868402 [TBL] [Abstract][Full Text] [Related]
54. Study on the role of humoral immunity in renal transplant rejections and its correlation with histopathological findings. Sonkar GK; ; Singh RG Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):901-10. PubMed ID: 21912017 [TBL] [Abstract][Full Text] [Related]
55. Immunologic enhancement of rat renal allografts. III. Immunopathologic lesions and rejection in long-surviving passively enhanced grafts. Abbas AK; Corson JM; Carpenter CB; Strom TB; Merrill JP; Dammin GJ Am J Pathol; 1975 May; 79(2):255-70. PubMed ID: 1096634 [TBL] [Abstract][Full Text] [Related]
56. An immunological study of renal allograft rejection using the direct macrophage inhibition test. Turnipseed WD; Cerilli J Transplantation; 1975 Nov; 20(5):414-9. PubMed ID: 1108315 [TBL] [Abstract][Full Text] [Related]
57. Identification of the antibody to vascular endothelial cells in patients undergoing cardiac transplantation. Brasile L; Zerbe T; Rabin B; Clarke J; Abrams A; Cerilli J Transplantation; 1985 Dec; 40(6):672-5. PubMed ID: 3907041 [TBL] [Abstract][Full Text] [Related]
58. Hyperacute rejection of living related kidney grafts caused by endothelial cell-specific antibodies: case reports. Grandtnerová B; Mäcková N; Hovoricová B; Jahnová E Transplant Proc; 2008 Sep; 40(7):2422-4. PubMed ID: 18790254 [TBL] [Abstract][Full Text] [Related]
59. Use of donor serum to prevent passive transfer of hyperacute rejection. Wang J; Geissler EK; Fechner JH; Burlingham WJ; Knechtle SJ J Surg Res; 1994 Jul; 57(1):150-5. PubMed ID: 8041130 [TBL] [Abstract][Full Text] [Related]
60. Influence of HLA matching on rejections and short- and long-term primary cadaveric allograft survival. Kerman RH; Kimball PM; Lindholm A; Van Buren CT; Katz SM; Lewis RM; McClain J; Podbielski J; Williams J; Kahan BD Transplantation; 1993 Nov; 56(5):1242-7. PubMed ID: 8249130 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]